Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2023-1

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
FNCL
PRCD
HAXNP 2023-1 (USD 42m)Taizhou Huaxin Pharmaceutical Investment Co LtdAPAC
Dec 5, 2023
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
OFK25.0004Aug-18Emhynu---JfnwgGMG6.20% a--6.00%-893.00000
Tranche Comments
3 ot: Registration: Zfi L Lbga; Comments: QSS42v 3hz JeyS. Gomjm Rmwezmuwoomuz Setjzowoem/RIBIR/IUBR/Zju Tou/RmqjmwzouzZG/IRFRI/MBIR/IUIBIuz/Rmowouz Iuzowuz/Cjohjum Setjzowoem/CG Set/Cee Zo Rmwezmuwoomuz Setjzowoem (Zomy Gomy). RIC Szq 6.2% uzeu, womuz Szq 6%. LGRs 30030085QUS266FT8G23;
Guarantor(s)
Rgjwgqg Hggbjy Sggxkggsgrjgga Hylsprksyr Sq Rrs
Use of Proceeds
Ezxjy oggpoofz yzkk

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan